How to stop and how long to continue Aldactone (spironolactone) for a 17-year-old?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Discontinue Spironolactone (Aldactone) in a 17-Year-Old

Spironolactone should be discontinued gradually by tapering the dose over several weeks rather than stopping abruptly, with close monitoring of electrolytes and renal function during the withdrawal process. 1

Duration of Treatment

The optimal duration of spironolactone treatment depends on the condition being treated:

  • For hyperandrogenic conditions (acne, hirsutism):

    • Treatment typically continues until satisfactory clinical response is achieved, usually for at least 6 months 2
    • Effects may persist for an average of 33.7 months after discontinuation in some patients 2
    • Some patients may require longer treatment periods (average treatment duration in studies was 28.5 months) 3
  • For heart failure (less likely indication in a 17-year-old):

    • Long-term treatment is typically recommended as long as the patient meets criteria and tolerates the medication 1

Discontinuation Protocol

Step 1: Evaluate Readiness to Discontinue

  • Assess if treatment goals have been achieved 2
  • Consider the risk of symptom recurrence (approximately 34% of patients with hyperandrogenic conditions relapse after discontinuation) 2

Step 2: Gradual Tapering

  • If on 100-200 mg daily: Reduce to 50 mg daily for 1-2 weeks 1
  • If on 50 mg daily: Reduce to 25 mg daily for 1-2 weeks 1
  • If on 25 mg daily: Switch to 25 mg every other day for 1-2 weeks before stopping 1

Step 3: Monitoring During Discontinuation

  • Check renal function and serum electrolytes 1-2 weeks after each dose reduction 1
  • Monitor for return of original symptoms 2

Post-Discontinuation Monitoring

  • For hyperandrogenic conditions: Monitor for recurrence of symptoms for at least 17-18 months (average time to relapse) 2
  • For heart failure patients: Continue regular monitoring of renal function and electrolytes for several months after discontinuation 1

Special Considerations for Adolescents

  • Adolescents may be more sensitive to hormonal fluctuations during withdrawal 3
  • Menstrual irregularities may occur during the tapering process 3, 4
  • If spironolactone was used for acne/hirsutism, consider alternative treatments if symptoms recur 2, 4

Potential Withdrawal Effects

  • Diuretic effects may diminish, potentially causing temporary fluid retention 3, 5
  • Menstrual cycle changes may occur 3, 4
  • Gradual return of original symptoms (acne, hirsutism) may be observed over weeks to months 2

Contraindications to Abrupt Discontinuation

  • Heart failure patients should never stop spironolactone abruptly due to risk of fluid retention and worsening heart failure 1
  • Patients with severe hyperkalemia (potassium >6.0 mmol/L) or significant renal dysfunction (creatinine >310 mmol/L) should stop immediately rather than taper 1

Follow-up Recommendations

  • Schedule follow-up appointment 1 month after complete discontinuation 1
  • Check electrolytes and renal function at this visit 1
  • Assess for return of original symptoms requiring treatment 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Long-term safety of spironolactone in acne: results of an 8-year followup study.

Journal of cutaneous medicine and surgery, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.